ACIP Recommends GSK’s 5-in-1 Meningococcal Vaccine

The CDC’s Advisory Committee on Immunization Practices recommended the use of  Penmenvy, GSK as part of the adolescent meningococcal vaccination schedule to protect against disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y).